Lotus Health Group Company

Equities

600186

CNE000000WY0

Food Processing

End-of-day quote Shanghai S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
4.32 CNY +3.10% Intraday chart for Lotus Health Group Company +3.85% -28.60%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Lotus Health Group Company Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Lotus Health to Buy 50% of Malaysian MSG Producer MT
Lotus Health Group Company entered into letter of intent to acquire 50% stake in Ajinoriki Msg Sdn. Bhd. from Loo Siew Kim and Kee Seok Chean. CI
Court Orders Lotus Health to Pay 37 Million Yuan in Overdue Loans to China Development Bank; Shares Down 4% MT
Lotus Health Faces Reconsideration Hearing for Nearly 102 Million Yuan Loan Dispute MT
Shanghai Bourse Questions Lotus Health Fund Sources for 693 Million Yuan Technology Contract MT
Lotus Health to Buy 330 Nvidia Servers For 693 Million Yuan MT
Lotus Health Group Company Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Tranche Update on Lotus Health Group Company's Equity Buyback Plan announced on May 25, 2022. CI
Lotus Health Group Company's Equity Buyback announced on May 25, 2022 has expired with 19,381,400 shares, representing 1.08% for CNY 50 million. CI
Lotus Health Group Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Tranche Update on Lotus Health Group Company's Equity Buyback Plan announced on May 25, 2022. CI
Lotus Health Group Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Tranche Update on Lotus Health Group Company's Equity Buyback Plan announced on May 25, 2022. CI
Lotus Health Group Company Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tranche Update on Lotus Health Group Company's Equity Buyback Plan announced on May 25, 2022. CI
Lotus Health Group Company Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Tranche Update on Lotus Health Group Company's Equity Buyback Plan announced on May 25, 2022. CI
Lotus Health Group Company announces an Equity Buyback for CNY 100 million worth of its shares. CI
Lotus Health Group Company authorizes a Buyback Plan. CI
Lotus Health Group Company Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Lotus Health Group Company Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Lotus Health Group Company Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Lotus Health Group Company announced that it has received CNY 993.545246 million in funding from a group of investors CI
Lotus Health Group Company Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Chart Lotus Health Group Company
More charts
Lotus Health Group Company, formerly Lotus Health Industry Holding Group Company, is a China-based company primarily engaged in the production and distribution of monosodium glutamate and other flavoring products. The Company's principal products are monosodium glutamate under the brand named Lotus Flower. The Company also offers chicken essence, soy sauce, vinegar, sodium glutamate, glutamic acid, amylaceum, cube sugar, flour, gluten powder, starch, vegetarian products, as well as feed and fertilizer, among others. The Company distributes its products in domestic and overseas markets.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 600186 Stock
  4. News Lotus Health Group Company
  5. Lotus Health to Buy 50% of Malaysian MSG Producer